DHR - Danaher Corporation
228.55
| Index: | S&P 500 | P/E: | 43.59 | EPS (ttm): | 5.24 | Insider Own: | 4.06% | Shs Outstand: | 722.20M | Perf Week: | -2.70% |
| Market Cap: | 166.82B | Forward P/E: | 27.42 | EPS next Y: | 8.34 | Insider Trans: | -0.30% | Shs Float: | 692.96M | Perf Month: | -1.95% |
| Income(ttm): | 3.89B | PEG: | 7.42 | EPS next Q: | 2.15 | Inst Own: | 80.59% | Short Float: | 0.78% | Perf Quarter: | -16.33% |
| Revenue(ttm): | 23.74B | P/S: | 7.03 | EPS this Y: | -1.15% | Inst Trans: | -1.87% | Short Ratio: | 1.87 | Perf Half Y: | -10.99% |
| Book/sh: | 71.03 | P/B: | 3.22 | EPS next Y: | 11.25% | ROA: | 4.67% | Short Interest: | 5.42M | Perf Year: | 0.77% |
| Cash/sh: | 3.60 | P/C: | 63.50 | EPS next 5Y: | 5.87% | ROE: | 7.59% | 52W Range: | 222.53 - 281.70 | Perf YTD: | -1.21% |
| Dividend Est.: | 1.10 (0.48%) | P/FCF: | 33.30 | EPS past 5Y: | 11.31% | ROI: | 5.76% | 52W High: | -18.87% | Beta: | 0.84 |
| Dividend TTM: | 1.05 (0.46%) | Quick Ratio: | 1.01 | Sales past 5Y: | 8.35% | Gross Margin: | 59.37% | 52W Low: | 2.71% | ATR (14): | 4.72 |
| Dividend Ex-Date: | Dec 27, 2024 | Current Ratio: | 1.37 | EPS Y/Y TTM: | -34.04% | Oper. Margin: | 20.44% | RSI (14): | 37.57 | Volatility: | 2.16% 1.90% |
| Employees: | 63000 | Debt/Eq: | 0.37 | Sales Y/Y TTM: | -19.70% | Profit Margin: | 16.39% | Recom: | 1.48 | Target Price: | 288.25 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.32 | EPS Q/Q: | -25.91% | Payout: | 16.45% | Rel Volume: | 2.42 | Prev Close: | 226.16 |
| Sales Surprise: | 3.78% | EPS Surprise: | 9.02% | Sales Q/Q: | -15.64% | Earnings: | Oct 22 BMO | Avg Volume: | 2.90M | Price: | 228.55 |
| SMA20: | -2.55% | SMA50: | -6.22% | SMA200: | -10.34% | Undervalued: 26.12% | Volume: | 7,033,388 | Change: | 1.06% | |
Graham Classic formula value: 95.24
(P/E=8 * 1g) Min value: 65.26
(current P/E * 2g) Max value: 260.34
Average value: 140.28
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.